Singapore markets closed

Medtronic plc (MDT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
79.99+0.72 (+0.91%)
At close: 04:00PM EST
79.32 -0.67 (-0.84%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 106.36B
Enterprise value 123.71B
Trailing P/E 25.97
Forward P/E 15.77
PEG Ratio (5 yr expected) 1.61
Price/sales (ttm)3.34
Price/book (mrq)2.07
Enterprise value/revenue 3.87
Enterprise value/EBITDA 14.02

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 31.52%
S&P500 52-week change 314.90%
52-week high 392.02
52-week low 368.84
50-day moving average 374.64
200-day moving average 381.86

Share statistics

Avg vol (3-month) 36.79M
Avg vol (10-day) 36.28M
Shares outstanding 51.33B
Implied shares outstanding 61.33B
Float 81.33B
% held by insiders 10.10%
% held by institutions 184.53%
Shares short (14 Nov 2023) 48.68M
Short ratio (14 Nov 2023) 41.11
Short % of float (14 Nov 2023) 40.65%
Short % of shares outstanding (14 Nov 2023) 40.65%
Shares short (prior month 12 Oct 2023) 49.5M

Dividends & splits

Forward annual dividend rate 42.76
Forward annual dividend yield 43.45%
Trailing annual dividend rate 32.74
Trailing annual dividend yield 33.46%
5-year average dividend yield 42.43
Payout ratio 488.96%
Dividend date 312 Oct 2023
Ex-dividend date 420 Sept 2023
Last split factor 22:1
Last split date 326 Sept 1999

Financial highlights

Fiscal year

Fiscal year ends 27 Apr 2023
Most-recent quarter (mrq)26 Oct 2023


Profit margin 12.84%
Operating margin (ttm)20.77%

Management effectiveness

Return on assets (ttm)4.23%
Return on equity (ttm)7.96%

Income statement

Revenue (ttm)31.96B
Revenue per share (ttm)24.02
Quarterly revenue growth (yoy)5.30%
Gross profit (ttm)N/A
Net income avi to common (ttm)4.1B
Diluted EPS (ttm)3.08
Quarterly earnings growth (yoy)112.90%

Balance sheet

Total cash (mrq)7.73B
Total cash per share (mrq)5.81
Total debt (mrq)25.08B
Total debt/equity (mrq)48.56%
Current ratio (mrq)2.29
Book value per share (mrq)38.69

Cash flow statement

Operating cash flow (ttm)5.57B
Levered free cash flow (ttm)4.61B